News & Publications


Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.

Prous Institute Presents the Prous Institute - Overton & Meyer Award for New Technologies in Drug Discovery to Dr Harren Jhoti

Berlin, Germany: Prous Institute for Biomedical Research presented the 2012 Prous Institute – Overton & Meyer Award, recognizing outstanding contributions to the development of new technologies in the field of medicinal chemistry, to Dr Harren Jhoti, at the 22nd International Symposium on Medicinal Chemistry organized by European Federation of Medicinal Chemistry (EFMC).

This award acknowledges Dr Jhoti’s contribution to the discovery and development of innovative technologies that advance the field of fragment-based drug discovery.

Dr Harren Jhoti is President and Member of the Board of Directors of Astex Pharmaceuticals, an integrated biotechnology company that is a leader in Fragment-Based Drug Discovery. He co-founded Astex in 1999 and was Chief Scientific Officer until November 2007 when he was appointed Chief Executive. Dr. Jhoti was named ‘Chemistry World Entrepreneur of the Year’ by the Royal Society of Chemistry in 2007. He has published widely, including leading journals such as Nature and Science and has also been featured in TIME magazine after being named a ‘Technology Pioneer’ by the World Economic Forum in 2005.

About Prous Institute - Overton & Meyer Award for New Technologies in Drug Discovery 

The "Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery" was established to encourage innovation and investigation in technologies related to drug discovery. The Award is given biennially to acknowledge the discovery, evaluation or use of a new technology.